- Report
- April 2025
Global
From €4370EUR$4,900USD£3,790GBP
- Report
- April 2025
Global
From €4370EUR$4,900USD£3,790GBP
- Report
- January 2026
- 193 Pages
Global
From €5217EUR$5,850USD£4,525GBP
- Report
- January 2026
- 194 Pages
Global
From €5217EUR$5,850USD£4,525GBP
- Report
- January 2026
- 402 Pages
Global
From €5217EUR$5,850USD£4,525GBP
- Report
- October 2025
- 250 Pages
Global
From €4004EUR$4,490USD£3,473GBP
- Report
- March 2025
- 200 Pages
Global
From €4004EUR$4,490USD£3,473GBP
- Report
- June 2025
- 120 Pages
Global
From €4370EUR$4,900USD£3,790GBP
- Report
- January 2026
- 190 Pages
Global
From €3513EUR$3,939USD£3,047GBP
- Report
- January 2026
- 182 Pages
Global
From €3513EUR$3,939USD£3,047GBP
- Report
- January 2026
- 196 Pages
Global
From €3513EUR$3,939USD£3,047GBP
- Report
- August 2025
- 197 Pages
Global
From €3513EUR$3,939USD£3,047GBP
- Report
- August 2025
- 184 Pages
Global
From €3513EUR$3,939USD£3,047GBP
- Report
- August 2025
- 197 Pages
Global
From €3513EUR$3,939USD£3,047GBP
- Report
- August 2025
- 181 Pages
Global
From €3513EUR$3,939USD£3,047GBP
- Report
- August 2025
- 192 Pages
Global
From €3513EUR$3,939USD£3,047GBP
- Report
- November 2025
Global
From €4370EUR$4,900USD£3,790GBP
- Report
- October 2025
Global
From €4370EUR$4,900USD£3,790GBP
- Report
- October 2025
Global
From €4370EUR$4,900USD£3,790GBP
- Report
- October 2025
Global
From €4370EUR$4,900USD£3,790GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more